Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tips for Understanding the Pathways of Pain & Choosing Treatments

Carina Stanton  |  Issue: May 2020  |  May 15, 2020

Lemau Studio / shutterstock.com

Lemau Studio / shutterstock.com

SNOWMASS VILLAGE, COLO.—The science underlying the neurobiology of chronic pain isn’t something rheumatologists often think about. However, pain is an important reason why patients see a rheumatologist. At the 2020 ACR Winter Symposium in January, Leslie Crofford, MD, gave two presentations addressing pain experienced by rheumatology patients, including a session on the fundamental mechanisms of pain and a discussion of pain associated with fibromyalgia.

Dr. Crofford is the Wilson Family Chair in Medicine, professor of medicine and pathology, microbiology and immunology, and chief of rheumatology at Vanderbilt University Medical Center, Nashville, Tenn. She has investigated pain mechanisms as part of her research on the systemic effects of inflammatory arthritis and the effects of central pain causing such conditions as fibromyalgia.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“It’s so important for rheumatologists to understand the different pathways involved in pain transmission, because we will be better prepared to accurately distinguish inflammatory versus central mechanisms of pain and prescribe the right treatment,” Dr. Crofford said.

Different Mechanisms for Pain

The source of pain in the body dictates where and how a patient experiences pain. During her session on different mechanisms of pain, Dr. Crofford explained the two primary pain mechanisms—peripheral and central.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Peripheral pain is initiated from a peripheral stimulus through the body’s noci­ceptors, such as skin, muscle, tendon or synovium, from which that pain signal is transmitted by primary afferent neurons to the dorsal root ganglion. From this point, the pain signal is transmitted to the spinal cord, then to projection neurons in higher centers within the brain.

When a nociceptor is repeatedly stimu­lated, sensitization occurs. This sensitization is defined as an “increased responsiveness and reduced threshold of nociceptive neurons in the periphery to the stimulation of their receptive fields,” Dr. Crofford said. Peripheral sensitization is often seen in conditions with chronic inflammation or joint damage, as in rheumatoid arthritis or osteoarthritis.

Central pain, caused by central sensitization, results from “increased responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold afferent input,” she explained. This neuron-mediated phenomenon causes neurons in the spinal cord to become more excitable, leading to a decreased pain threshold to noxious stimuli, an enhanced response to non-noxious stimuli or an increase in spontaneous nerve activity, resulting in such conditions as fibromyalgia.

Clinical Characteristics of Pain

With a clear understanding of peripheral and central pain mechanisms, a rheumatologist can ask a patient how they are experiencing their pain to better determine underlying causes and potential treatment approaches. Examples: If a patient describes their pain as difficult to localize or moving around different locations, this is likely the result of central pain and may be accompanied by somatic symptoms, such as fatigue, cognitive difficulties, depression and anxiety.

Page: 1 2 3 | Single Page
Share: 

Filed under:AnalgesicsConditions Tagged with:Pain Managementpain mechanismspain pathwaysWinter Rheumatology Summit

Related Articles

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Using Different Fibromyalgia Criteria Affects Prevalence Estimates

    September 14, 2021

    A recent paper illustrates how using different fibromyalgia criteria affects reports of its prevalence.1 Writing in Arthritis Care & Research, researchers found the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks–American Pain Society Pain Taxonomy (AAPT) criteria caused far more people to be categorized as having fibromyalgia than criteria put forth by…

    Pain in Rheumatoid Arthritis

    October 7, 2011

    Out from the shadow of inflammation

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences